Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients.

Robinson PC, Costello ME, Leo P, Bradbury LA, Hollis K, Cortes A, Lee S, Joo KB, Shim SC, Weisman M, Ward M, Zhou X, Garchon HJ, Chiocchia G, Nossent J, Lie BA, Førre Ø, Tuomilehto J, Laiho K, Jiang L, Liu Y, Wu X, Elewaut D, Burgos-Vargas R, Gensler LS, Stebbings S, Haroon N, Mulero J, Fernandez-Sueiro JL, Gonzalez-Gay MA, Lopez-Larrea C, Bowness P, Gafney K, Gaston JS, Gladman DD, Rahman P, Maksymowych WP, Xu H, van der Horst-Bruinsma IE, Chou CT, Valle-Oñate R, Romero-Sánchez MC, Hansen IM, Pimentel-Santos FM, Inman RD, Martin J, Breban M, Evans D, Reveille JD, Kim TH, Wordsworth BP, Brown MA.

Ann Rheum Dis. 2015 Aug;74(8):1627-9. doi: 10.1136/annrheumdis-2015-207416. Epub 2015 Apr 27. No abstract available.

2.

PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis.

Julià A, Rodríguez J, Fernández-Sueiro JL, Gratacós J, Queiró R, Montilla C, Torre-Alonso JC, Pérez-Venegas JJ, Manrique-Arija S, Muñoz-Fernández S, González C, Roig D, Zarco P, Erra A, Castañeda S, García A, Salvador G, Díaz-Torne C, Blanco R, Domínguez AW, Mosquera JA, Vela P, Tornero J, Sánchez-Fernández S, Corominas H, Ramírez J, Avila G, Alonso A, Tortosa R, López-Lasanta M, Cañete JD, Marsal S.

Pharmacogenomics. 2014 Nov;15(14):1763-1769.

PMID:
25493569
3.

Individual telomere length decay in patients with spondyloarthritis.

Tamayo M, Pértega S, Mosquera A, Rodríguez M, Blanco FJ, Fernández-Sueiro JL, Gosálvez J, Fernández JL.

Mutat Res. 2014 Jul;765:1-5. doi: 10.1016/j.mrfmmm.2014.04.006. Epub 2014 Apr 24.

PMID:
24769426
4.

Standards of care for patients with spondyloarthritis.

Abad MÁ, Ariza RA, Aznar JJ, Batlle E, Beltrán E, de Dios Cañete J, de Miguel E, Escudero A, Fernández-Carballido C, Gratacós J, Loza E, Linares LF, Montilla C, Ramos MM, Mulero J, Queiro R, Raya E, Lozano CR, Moreno JR, Sanz J, Silva-Fernández L, Torre Alonso JC, Zarco P, Fernández-Sueiro JL, Juanola X; 2e study group; Spanish Society of Rheumatology.

Rheumatol Int. 2014 Feb;34(2):165-70. doi: 10.1007/s00296-013-2934-6. Epub 2014 Jan 4. Review.

PMID:
24390635
5.

Scoring with the Berlin MRI method for assessment of spinal inflammatory activity in patients with ankylosing spondylitis: a calibration exercise among rheumatologists.

Carmona L, Sellas A, Rodríguez-Lozano C, Juanola X, García Llorente JF, Fernández Sueiro JL, Linares LF, de Castro MC, Moreno M, Zarco P, Ariza R, Baraliakos X, de Miguel E.

Clin Exp Rheumatol. 2013 Nov-Dec;31(6):883-8. Epub 2013 Dec 20.

PMID:
24373323
6.

Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.

International Genetics of Ankylosing Spondylitis Consortium (IGAS), Cortes A, Hadler J, Pointon JP, Robinson PC, Karaderi T, Leo P, Cremin K, Pryce K, Harris J, Lee S, Joo KB, Shim SC, Weisman M, Ward M, Zhou X, Garchon HJ, Chiocchia G, Nossent J, Lie BA, Førre Ø, Tuomilehto J, Laiho K, Jiang L, Liu Y, Wu X, Bradbury LA, Elewaut D, Burgos-Vargas R, Stebbings S, Appleton L, Farrah C, Lau J, Kenna TJ, Haroon N, Ferreira MA, Yang J, Mulero J, Fernandez-Sueiro JL, Gonzalez-Gay MA, Lopez-Larrea C, Deloukas P, Donnelly P; Australo-Anglo-American Spondyloarthritis Consortium (TASC); Groupe Française d'Etude Génétique des Spondylarthrites (GFEGS); Nord-Trøndelag Health Study (HUNT); Spondyloarthritis Research Consortium of Canada (SPARCC); Wellcome Trust Case Control Consortium 2 (WTCCC2), Bowness P, Gafney K, Gaston H, Gladman DD, Rahman P, Maksymowych WP, Xu H, Crusius JB, van der Horst-Bruinsma IE, Chou CT, Valle-Oñate R, Romero-Sánchez C, Hansen IM, Pimentel-Santos FM, Inman RD, Videm V, Martin J, Breban M, Reveille JD, Evans DM, Kim TH, Wordsworth BP, Brown MA.

Nat Genet. 2013 Jul;45(7):730-8. doi: 10.1038/ng.2667. Epub 2013 Jun 9.

7.

Comparison of 2 referral strategies for the diagnosis of axial spondyloarthritis in Spain. The RADAR study.

Juanola X, Fernández-Sueiro JL, Torre-Alonso JC, Miguélez R, Muñoz-Fernández S, Ballina J, González C, Juliá B, Cea-Calvo L, Collantes E.

Reumatol Clin. 2013 Nov-Dec;9(6):348-52. doi: 10.1016/j.reuma.2013.02.009. Epub 2013 Jun 2. English, Spanish.

8.

Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease.

Cénit MC, Ortego-Centeno N, Raya E, Callejas JL, García-Hernandez FJ, Castillo-Palma MJ, Fernandez-Sueiro JL, Magro C, Solans R, Castañeda S, Camps M, Hidalgo A, Espinosa G, González-Gay MA, González-Escribano MF, Martín J.

Hum Immunol. 2013 Feb;74(2):230-3. doi: 10.1016/j.humimm.2012.10.019. Epub 2012 Nov 2.

PMID:
23127549
9.

Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes.

Julià A, Tortosa R, Hernanz JM, Cañete JD, Fonseca E, Ferrándiz C, Unamuno P, Puig L, Fernández-Sueiro JL, Sanmartí R, Rodríguez J, Gratacós J, Dauden E, Sánchez-Carazo JL, López-Estebaranz JL, Moreno-Ramírez D, Queiró R, Montilla C, Torre-Alonso JC, Pérez-Venegas JJ, Vanaclocha F, Herrera E, Muñoz-Fernández S, González C, Roig D, Erra A, Acosta I, Fernández-Nebro A, Zarco P, Alonso A, López-Lasanta M, García-Montero A, Gelpí JL, Absher D, Marsal S.

Hum Mol Genet. 2012 Oct 15;21(20):4549-57. Epub 2012 Jul 19.

PMID:
22814393
10.

Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features.

Celis R, Planell N, Fernández-Sueiro JL, Sanmartí R, Ramírez J, González-Álvaro I, Pablos JL, Cañete JD.

Arthritis Res Ther. 2012 Apr 27;14(2):R93. doi: 10.1186/ar3817.

11.

Fibromyalgia and enthesitis in psoriatic arthritis. Time to "characterize" and "refine" clinical definitions.

Fernández-Sueiro JL.

J Rheumatol. 2012 Apr;39(4):677-8. doi: 10.3899/jrheum.120095. No abstract available.

PMID:
22467947
12.

FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-α blockers in psoriatic arthritis: a longitudinal study with 6 months of followup.

Ramírez J, Fernández-Sueiro JL, López-Mejías R, Montilla C, Arias M, Moll C, Alsina M, Sanmarti R, Lozano F, Cañete JD.

J Rheumatol. 2012 May;39(5):1035-41. doi: 10.3899/jrheum.110980. Epub 2012 Apr 1.

PMID:
22467926
13.

Clinical features of late-onset ankylosing spondylitis: comparison with early-onset disease.

Montilla C, Del Pino-Montes J, Collantes-Estevez E, Font P, Zarco P, Mulero J, Gratacós J, Rodríguez C, Juanola X, Fernández-Sueiro JL, Almodovar R; REGISPONSER Study Group.

J Rheumatol. 2012 May;39(5):1008-12. doi: 10.3899/jrheum.111082. Epub 2012 Mar 15.

PMID:
22422491
14.

[Prognostic factors in psoriatic arthritis].

Fernández Sueiro JL, Lema Gontad JM.

Reumatol Clin. 2012 Mar;8 Suppl 1:S7-9. doi: 10.1016/j.reuma.2011.10.015. Epub 2012 Jan 17. Review. Spanish.

15.

[Consensus statement of the Spanish Society of Rheumatology on risk management of biologic therapy in rheumatic patients].

Gómez Reino J, Loza E, Andreu JL, Balsa A, Batlle E, Cañete JD, Collantes Estévez E, Fernández Carballido C, Fernández Sueiro JL, García de Vicuña R, González-Álvaro I, González Fernández C, Juanola X, Linares LF, Marenco JL, Martín Mola E, Moreno Ramos M, Mulero Mendoza J, Muñoz Fernández S, Queiro R, Richi Alberti P, Sanz J, Tornero Molina J, Zarco Montejo P, Carmona L; Sociedad Española de Reumatología.

Reumatol Clin. 2011 Sep-Oct;7(5):284-98. doi: 10.1016/j.reuma.2011.05.002. Epub 2011 Aug 4. Spanish.

16.

[Consensus statement of the Spanish Society of Rheumatology on the management of biologic therapies in psoriatic arthritis].

Fernández Sueiro JL, Juanola Roura X, Cañete Crespillo Jde D, Torre Alonso JC, García de Vicuña R, Queiro Silva R, Ariza Ariza R, Batlle Gualda E, Loza Santamaría E; Sociedad Española de Reumatología [Spanish Society of Rheumatology].

Reumatol Clin. 2011 May-Jun;7(3):179-88. doi: 10.1016/j.reuma.2011.02.001. Epub 2011 Mar 21. Spanish.

17.

High-dose etanercept in ankylosing spondylitis: results of a 12-week randomized, double blind, controlled multicentre study (LOADET study).

Navarro-Sarabia F, Fernández-Sueiro JL, Torre-Alonso JC, Gratacos J, Queiro R, Gonzalez C, Loza E, Linares L, Zarco P, Juanola X, Román-Ivorra J, Martín-Mola E, Sanmartí R, Mulero J, Diaz G, Armendáriz Y, Collantes E.

Rheumatology (Oxford). 2011 Oct;50(10):1828-37. doi: 10.1093/rheumatology/ker083. Epub 2011 Jun 23.

PMID:
21700683
18.

Deletion of LCE3C and LCE3B is a susceptibility factor for psoriatic arthritis: a study in Spanish and Italian populations and meta-analysis.

Docampo E, Giardina E, Riveira-Muñoz E, de Cid R, Escaramís G, Perricone C, Fernández-Sueiro JL, Maymó J, González-Gay MA, Blanco FJ, Hüffmeier U, Lisbona MP, Martín J, Carracedo A, Reis A, Rabionet R, Novelli G, Estivill X.

Arthritis Rheum. 2011 Jul;63(7):1860-5. doi: 10.1002/art.30340.

19.

Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis.

Montala N, Juanola X, Collantes E, Muñoz-Gomariz E, Gonzalez C, Gratacos J, Zarco P, Fernandez Sueiro JL, Mulero J, Torre-Alonso JC, Batlle E, Carmona L.

J Rheumatol. 2011 May;38(5):893-7. doi: 10.3899/jrheum.100851. Epub 2011 Mar 1.

PMID:
21362760
20.

Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study.

Cauli A, Gladman DD, Mathieu A, Olivieri I, Porru G, Tak PP, Sardu C, Ujfalussy I, Scarpa R, Marchesoni A, Taylor WJ, Spadaro A, Fernàndez-Sueiro JL, Salvarani C, Kalden JR, Lubrano E, Carneiro S, Desiati F, Flynn JA, D'Angelo S, Vacca A, VAN Kuijk AW, Catanoso MG, Gruenke M, Peluso R, Parsons WJ, Ferrara N, Contu P, Helliwell PS, Mease PJ; GRAPPA 3PPsA Study Group.

J Rheumatol. 2011 May;38(5):898-903. doi: 10.3899/jrheum.100857. Epub 2011 Feb 15.

PMID:
21324965
21.

Power Doppler ultrasonography assessment of entheses in spondyloarthropathies: response to therapy of entheseal abnormalities.

Naredo E, Batlle-Gualda E, García-Vivar ML, García-Aparicio AM, Fernández-Sueiro JL, Fernández-Prada M, Giner E, Rodriguez-Gomez M, Pina MF, Medina-Luezas JA, Toyos FJ, Campos C, Gutiérrez-Polo R, Ferrer MA, Martínez O, Díaz-Torne C, Gonzalez T, Campos S, Queiro R, Castaño-Sánchez M, Aznar JJ, Bustabad S, Paez-Camino M, Tuneu R, Ruiz T, Mateo L, Pujol M, Ponce A, Ros I, Gallegos A, Moreno J, Gumbau D, Sianes M, Poveda-Elices MJ, Romero-Gómez M, Raya E; Ultrasound Group of the Spanish Society of Rheumatology.

J Rheumatol. 2010 Oct;37(10):2110-7. doi: 10.3899/jrheum.100136. Epub 2010 Sep 1.

PMID:
20810495
22.

Possible association between NOD2 variants and joint surgery in psoriatic arthritis.

Graell E, Arostegui JI, Sanmartí R, Blanco FJ, Yagüe J, Pinto JA, Plaza S, Fernández-Sueiro JL, González A, Cañete JD.

Clin Exp Rheumatol. 2010 Jan-Feb;28(1):30-4.

PMID:
20346235
23.

Validity of the bath ankylosing spondylitis disease activity index for the evaluation of disease activity in axial psoriatic arthritis.

Fernández-Sueiro JL, Willisch A, Pértega-Díaz S, Tasende JA, Fernández-López JC, Villar NO, Galdo F, Blanco FJ.

Arthritis Care Res (Hoboken). 2010 Jan 15;62(1):78-85. doi: 10.1002/acr.20017.

24.

[Axial psoriatic arthritis].

Fernández Sueiro JL, González Díaz De Rábago E.

Reumatol Clin. 2010 Mar;6 Suppl 1:22-4. doi: 10.1016/j.reuma.2009.12.007. Epub 2010 Feb 12. Spanish.

25.

The challenge and need of defining axial psoriatic arthritis.

Fernández-Sueiro JL.

J Rheumatol. 2009 Dec;36(12):2633-4. doi: 10.3899/jrheum.091023. No abstract available.

PMID:
19966191
26.

Differing patterns of peripheral blood leukocyte telomere length in rheumatologic diseases.

Tamayo M, Mosquera A, Rego JI, Fernández-Sueiro JL, Blanco FJ, Fernández JL.

Mutat Res. 2010 Jan 5;683(1-2):68-73. doi: 10.1016/j.mrfmmm.2009.10.010.

PMID:
19879280
27.

Work disability in patients with ankylosing spondylitis.

Ariza-Ariza R, Hernández-Cruz B, Collantes E, Batlle E, Fernández-Sueiro JL, Gratacós J, Juanola X, Linares LF, Mulero J, Zarco P.

J Rheumatol. 2009 Nov;36(11):2512-6. doi: 10.3899/jrheum.090481. Epub 2009 Oct 15.

PMID:
19833749
28.

Relationship between spinal mobility and disease activity, function, quality of life and radiology. A cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER).

Almodóvar R, Zarco P, Collantes E, González C, Mulero J, Fernández-Sueiro JL, Gratacós J, Torres-Alonso JC, Juanola X, Batlle E, Ariza R, Muñoz E.

Clin Exp Rheumatol. 2009 May-Jun;27(3):439-45.

PMID:
19604436
29.

Evaluation of ankylosing spondylitis spinal mobility measurements in the assessment of spinal involvement in psoriatic arthritis.

Fernández-Sueiro JL, Willisch A, Pértega-Díaz S, Tasende JA, Fernández-Lopez C, Galdo F, Blanco FJ.

Arthritis Rheum. 2009 Mar 15;61(3):386-92. doi: 10.1002/art.24280.

30.

The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis.

Rueda B, Orozco G, Raya E, Fernandez-Sueiro JL, Mulero J, Blanco FJ, Vilches C, González-Gay MA, Martin J.

Ann Rheum Dis. 2008 Oct;67(10):1451-4. doi: 10.1136/ard.2007.080283. Epub 2008 Jan 16.

PMID:
18199597
31.

Polymorphisms in genes encoding tumor necrosis factor-alpha and HLA-DRB1 are not associated with response to infliximab in patients with rheumatoid arthritis.

Pinto JA, Rego I, Rodríguez-Gomez M, Cañete JD, Fernandez-López C, Freire M, Fernandez-Sueiro JL, Sanmarti R, Blanco FJ.

J Rheumatol. 2008 Jan;35(1):177-8. No abstract available. Erratum in: J Rheumatol. 2008 Mar;35(3):546.

PMID:
18176993
32.

¿Cómo evaluamos una artritis psoriásica? ¿Cuál es el mejor método?

Fernández Sueiro JL.

Reumatol Clin. 2007 Nov;3(6):243-4. doi: 10.1016/S1699-258X(07)73697-5. Epub 2008 Nov 13. Spanish. No abstract available.

33.

Actualización del Consenso de la Sociedad Española de Reumatología sobre el uso de antagonistas del TNFα en las espondiloartritis, incluida la artritis psoriásica.

Collantes E, Fernández Sueiro JL, García-Vicuña R, Gratacós J, Mulero J, Muñoz Fernández S, Sanmartí R, Zarco P, Angel Abad M, Batlle E, de Dios Cañete J, González Crespo MR, González C, Juanola X, Sanz J, Rivera J.

Reumatol Clin. 2007 Jul;3 Suppl 2:S60-70. doi: 10.1016/S1699-258X(07)73645-8. Epub 2008 Dec 29. Spanish. No abstract available.

34.

Nuevos criterios de clasificación en la artritis psoriásica.

Fernández Sueiro JL, Pértega Díaz S.

Reumatol Clin. 2007 Jul;3 Suppl 2:S10-5. doi: 10.1016/S1699-258X(07)73633-1. Epub 2008 Dec 29. Spanish. No abstract available.

35.

Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended report.

Collantes E, Zarco P, Muñoz E, Juanola X, Mulero J, Fernández-Sueiro JL, Torre-Alonso JC, Gratacós J, González C, Batlle E, Fernández P, Linares LF, Brito E, Carmona L.

Rheumatology (Oxford). 2007 Aug;46(8):1309-15. Epub 2007 May 27.

PMID:
17526930
36.

[Enthesis as a target element in spondylarthritides].

Fernández-Sueiro JL.

Reumatol Clin. 2006 Jan;2(1):31-5. doi: 10.1016/S1699-258X(06)73017-0. Epub 2008 Dec 30. Spanish.

37.

Multiple parosteal lipoma associated to polyarthritis.

Fernández-Sueiro JL, Pinto JA, Blanco FJ, Freire M, Veiga JA, Galdo F, González-Gay MA.

Joint Bone Spine. 2006 Mar;73(2):202-4. Epub 2005 Jun 8.

PMID:
16226479
38.

Prevalence of HLA-B27 and subtypes of HLA-B27 associated with ankylosing spondylitis in Galicia, Spain.

Fernández-Sueiro JL, Alonso C, Blanco FJ, Rodríguez-Gómez M, Galdo F, González-Gay MA.

Clin Exp Rheumatol. 2004 Jul-Aug;22(4):465-8.

PMID:
15301245
39.

Pig chondrocyte xenoimplants for human chondral defect repair: an in vitro model.

Fuentes-Boquete I, López-Armada MJ, Maneiro E, Fernández-Sueiro JL, Caramés B, Galdo F, de Toro FJ, Blanco FJ.

Wound Repair Regen. 2004 Jul-Aug;12(4):444-52.

PMID:
15260810
40.

Xeno-implantation of pig chondrocytes into rabbit to treat localized articular cartilage defects: an animal model.

Ramallal M, Maneiro E, López E, Fuentes-Boquete I, López-Armada MJ, Fernández-Sueiro JL, Galdo F, De Toro FJ, Blanco FJ.

Wound Repair Regen. 2004 May-Jun;12(3):337-45.

PMID:
15225212
41.

The biological action of hyaluronan on human osteoartritic articular chondrocytes: the importance of molecular weight.

Maneiro E, de Andres MC, Fernández-Sueiro JL, Galdo F, Blanco FJ.

Clin Exp Rheumatol. 2004 May-Jun;22(3):307-12.

PMID:
15144124
42.

Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes.

Maneiro E, Martín MA, de Andres MC, López-Armada MJ, Fernández-Sueiro JL, del Hoyo P, Galdo F, Arenas J, Blanco FJ.

Arthritis Rheum. 2003 Mar;48(3):700-8.

43.

Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes.

Maneiro E, López-Armada MJ, Fernández-Sueiro JL, Lema B, Galdo F, Blanco FJ.

J Rheumatol. 2001 Dec;28(12):2692-9.

PMID:
11764219
44.

Severe myelotoxicity in rheumatoid arthritis patients treated with oral methotrexate.

Rodriguez-Gomez M, Fernandez-Sueiro JL, Ulibarrena C, Lopez-Barros G, Willisch A, Fernandez-Dominguez L.

Clin Exp Rheumatol. 2001 May-Jun;19(3):353. No abstract available.

PMID:
11407096
45.

Multifocal dactylitis as the sole clinical expression of sarcoidosis.

Rodriguez-Gomez M, Fernandez-Sueiro JL, Willisch A, Fernandez-Dominguez L, Lopez-Barros G, Vega-Vazquez F.

J Rheumatol. 2000 Jan;27(1):245-7. No abstract available.

PMID:
10648047
46.

Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica.

Rodriguez-Valverde V, Sarabia JM, González-Gay MA, Figueroa M, Armona J, Blanco R, Fernández-Sueiro JL, Martínez-Taboada VM.

Am J Med. 1997 Apr;102(4):331-6.

PMID:
9217613
47.

Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate. A more benign syndrome.

González-Gay MA, Rodríguez-Valverde V, Blanco R, Fernández-Sueiro JL, Armona J, Figueroa M, Martínez-Taboada VM.

Arch Intern Med. 1997 Feb 10;157(3):317-20.

PMID:
9040299
48.

Acute febrile toxic reaction in patients with refractory rheumatoid arthritis who are receiving combined therapy with methotrexate and azathioprine.

Blanco R, Martínez-Taboada VM, González-Gay MA, Armona J, Fernández-Sueiro JL, González-Vela MC, Rodríguez-Valverde V.

Arthritis Rheum. 1996 Jun;39(6):1016-20. Review.

PMID:
8651964
49.

Mononeuritis multiplex in systemic lupus erythematosus: response to pulse intravenous cyclophosphamide.

Martinez-Taboada VM, Alonso RB, Armona J, Fernandez-Sueiro JL, Gonzalez Vela C, Rodriguez-Valverde V.

Lupus. 1996 Feb;5(1):74-6. Review.

PMID:
8646231
50.

T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats.

Breban M, Fernández-Sueiro JL, Richardson JA, Hadavand RR, Maika SD, Hammer RE, Taurog JD.

J Immunol. 1996 Jan 15;156(2):794-803.

PMID:
8543835

Supplemental Content

Loading ...
Support Center